Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 76.66
+5.66 (7.97%)
Oct 15, 2026, 9:51 AM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 756.18 million as of October 15, 2026. It is the 14,768th most valuable company in the world and the 349th biggest in Canada. Its market cap has increased by 11.46% in one year.
Market Cap
756.18M
Enterprise Value
448.42M
Revenue
n/a
Global Rank
Country Rank
#349 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 756.18M, an increase of 1,317.78%. That is a compound annual growth rate of 59.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 756.18M | -12.07% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 700.59M |
| Satellos Bioscience | 227.23M |
| Eastwood Bio-Medical Canada | 133.64M |
| ME Therapeutics Holdings | 85.09M |
| Helix BioPharma | 70.27M |
| NurExone Biologic | 57.84M |
| BriaCell Therapeutics | 48.81M |
| Sernova Biotherapeutics | 43.43M |